BridgeMD
New treatment option for Depression
Official title Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
ClinicalTrials.gov ID: NCT02604277
What this study is testing
- What it's testing
- The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- English speaking
- Diagnosis of Bipolar Disorder (BD)
- Able to provide written informed consent
You likely can't join if
- Cognitive impairments
- Acutely psychotic
- Medically unstable
- History of schizophrenia spectrum disorder
- History of mood incongruent psychotic symptoms
- History of primary substance disorder
See the full eligibility criteria
- English speaking
- Diagnosis of Bipolar Disorder (BD)
- Able to provide written informed consent
- Cognitive impairments
- Acutely psychotic
- Medically unstable
- History of schizophrenia spectrum disorder
- History of mood incongruent psychotic symptoms
- History of primary substance disorder
- History of primary organic disease and/or dementia
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.